-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
1/25
Physical rehabilitation for critical illness myopathy and
neuropathy (Review)
Mehrholz J, Pohl M, Kugler J, Burridge J, Mückel S, Elsner B
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2015, Issue 3
http://www.thecochranelibrary.com
Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
http://www.thecochranelibrary.com/http://www.thecochranelibrary.com/
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
2/25
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
7DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15 APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
iPhysical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
3/25
[Intervention Review]
Physical rehabilitation for critical illness myopathy andneuropathy
Jan Mehrholz1,2, Marcus Pohl3, Joachim Kugler2, Jane Burridge4, Simone Mückel1, Bernhard Elsner2
1 Wissenschaftliches Institut, Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH, Kreischa, Germany.2Department of Public Health, Dresden Medical School, Technical University Dresden, Dresden, Germany. 3 Abteilung Neurologie
und Fachübergreifende Rehabilitation, Klinik Bavaria Kreischa, Kreischa, Germany. 4Research Group, Faculty of Health Sciences,
University of Southampton, Southampton, UK
Contact address: Jan Mehrholz, Wissenschaftliches Institut, Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa
GmbH, An der Wolfsschlucht 1-2, Kreischa, 01731, Germany. [email protected].
Editorial group: Cochrane Neuromuscular Disease Group.
Publication status and date: New, published in Issue 3, 2015.
Review content assessed as up-to-date: 14 July 2014.
Citation: Mehrholz J, Pohl M, Kugler J, Burridge J, Mückel S, Elsner B. Physical rehabilitation for critical illness myopathy and
neuropathy. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD010942. DOI: 10.1002/14651858.CD010942.pub2.
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Intensive care unit (ICU) acquired or generalised weakness due to critical illness myopathy (CIM) and polyneuropathy (CIP) are major
causes of chronically impaired motor function that can affect activities of daily living and quality of life. Physical rehabilitation of those
affected might help to improve activities of daily living.
Objectives
Our primary objective was to assess the effects of physical rehabilitation therapies and interventions for people with CIP and CIM in
improving activities of daily living such as walking, bathing, dressing and eating. Secondary objectives were to assess effects on muscle
strength and quality of life, and to assess adverse effects of physical rehabilitation.
Search methods
On 16 July 2014 we searched the Cochrane Neuromuscular Disease Group Specialized Register and on 14 July 2014 we searched
CENTRAL, MEDLINE, EMBASE and CINAHL Plus. In July 2014, we searched the Physiotherapy Evidence Database (PEDro,
http://www.pedro.org.au/) and three trials registries for ongoing trials and further data about included studies. There were no language
restrictions. We also handsearched relevant conference proceedings and screened reference lists to identify further trials.
Selection criteria
Weplanned to include randomised controlled trials (RCTs), quasi-RCTs and randomised controlled cross-over trials of any rehabilitation
intervention in people with acquired weakness syndrome due to CIP/CIM.
Data collection and analysis
We would have extracted data, assessed the risk of bias and classified the quality of evidence for outcomes in duplicate, according to
the standard procedures of The Cochrane Collaboration. Outcome data collection would have been for activities of daily living (for
example, mobility, walking, transfers and self care). Secondary outcomes included muscle strength, quality of life and adverse events.
1Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
mailto:[email protected]://www.pedro.org.au/http://www.pedro.org.au/http://www.pedro.org.au/http://www.pedro.org.au/mailto:[email protected]
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
4/25
Main results
The search strategy retrieved 3587 references. After examination of titles and abstracts, we retrieved the full text of 24 potentially
relevant studies. None of these studies met the inclusion criteria of our review. No data were suitable to be included in a meta-analysis.
Authors’ conclusions
There are no published RCTs or quasi-RCTs that examine whether physical rehabilitation interventions improve activities of daily
living for people with CIP and CIM. Large RCTs, which are feasible, need to be conducted to explore the role of physical rehabilitation
interventions for people with CIP and CIM.
P L A I N L A N G U A G E S U M M A R Y
Rehabilitation interventions for people with critical illness myopathy and neuropathy
Review question
Does physical rehabilitation aid recovery of people with weakness that develops in muscles (critical illness myopathy, CIM) and nerves
(critical illness polyneuropathy, CIP) in critical care?
Background
CIM and CIP are common complications of critical care. Both CIM and CIP cause limb weakness and weakness of muscles used for
breathing. CIM and CIP make people more unwell, increase mortality and slow down recovery. CIP and CIM are major causes of
long-term difficulties with movement. These difficulties can affect ’activities of daily living’ - everyday tasks such as bathing, dressing,
eating, leisure activities and participation in family life). Recovery takes weeks or months. When CIM/CIP is severe, there may be little
or no recovery.
Physical rehabilitation for people with CIM or CIP may help recovery and improve activities of daily living and may prevent complica-
tions. Physical rehabilitation includes stretching exercises and training to build up strength, and practical training in dressing, transfers
(e.g. from chair to bed), rising from sitting to standing, walking and balance.
Study characteristics
We carried out an extensive search of the medical literature for randomised controlled trials (RCTs) of physical rehabilitation treatments
for CIM or CIP.
Key results
We found no high quality trials that met our stringent criteria for inclusion in this review.
Quality of the evidence
Currently there are no RCTs that test whether physical rehabilitation improves activities of daily living for people with CIM/CIP. Well-
conducted research is required to determine the effects of rehabilitation in CIM/CIP.
This evidence is up to date to July 2014.
B A C K G R O U N D
Description of the condition
Critical illness myopathy (CIM) and polyneuropathy (CIP) are
common complications of critical illness that frequently occur
2Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
5/25
together. Both conditions cause weakness of limb and respiratory
muscles, and consequently increase morbidity and mortality, and
impede recovery.
CIP is a distal axonal sensory-motor polyneuropathy, which means
that multiple nerves that control movement and transmit sen-
sory information are affected. CIP presents as limb and respira-tory muscle weakness (Fan 2012; Lacomis 2000), and is closely
associated with a failure to wean people from mechanical ventila-
tion (Fan 2012; Latronico 2011). The diagnostic criteria for CIP
as a dysfunction of (multiple) peripheral nerves are, according to
Bolton 2005 and Latronico 2011, as follows:
1. The individual is critically ill (multi-organ dysfunction and
failures).
2. The individual has limb weakness, or is difficult to wean
from a ventilator (after exclusion of non-neuromuscular causes
such as heart and lung disease).
3. There is electrophysiological evidence of axonal motor and
sensory polyneuropathy.
4. There is an absence of a decremental response on repetitivenerve stimulation (Latronico 2011).
A definite diagnosis of CIP, according to Bolton 2005 and
Latronico 2011, is established if all four criteria are fulfilled. A
probable diagnosis of CIP is established if criteria one, three and
four are fulfilled.
CIM is a primary myopathy (i.e. a muscle disorder) that is not
secondary to muscle denervation, and which has characteristic
electrophysiological andmorphological changes (Latronico 2011).
The diagnostic criteria for critical illness myopathy are, according
to Latronico 2011, as follows:
1. The individual is critically ill (multi-organ dysfunction and
failures).
2. The individual has limb weakness, or is difficult to weanfrom a ventilator (after exclusion of non-neuromuscular causes
such as heart and lung disease).
3. Compound muscle action potential (CMAP) amplitudes
are less than 80% of the lower limit of normal in two or more
nerves when recorded without conduction block.
4. Sensory nerve action potential amplitudes are more than
80% of the lower limit of normal.
5. Needle electromyography detected:
i) short duration, low-amplitude motor unit potentials
with early or normal full recruitment, with or without
fibrillation potentials in conscious and co-operative patients; or
ii) increased CMAP duration or reduced muscle
membrane excitability on direct muscle stimulation in non-co-operative patients.
6. Absence of a decreasing response to repetitive nerve
stimulation.
7. Muscle histopathological findings of primary myopathy (for
example, myosin loss or muscle necrosis).
Fulfilment of all criteria establishes a definite diagnosis of CIM
(Latronico 2011). Fulfilment of only criteria one and three to six
establishes a probable diagnosis of CIM. For our review we will
apply these definitions of CIP and CIM.
The pathophysiology of CIP and CIM is complex and remains
unclear (Hermans 2008). The development of CIP and CIM is
thought to involve electrical, microvascular, metabolic and bioen-
ergetic pathophysiological mechanisms (see Hermans 2008 for a good overview). Crucial risk factors for CIP and CIM are sep-
sis, systemic inflammatory response syndrome and multiple organ
failure (Hermans 2008).
Exact numbers and rates of CIP and CIM are not well established
because of variations in the patient population, risk factors and the
diagnostic and assessment criteria used. In people receiving me-
chanical ventilation or with an increased risk of developing multi-
organ failure, the risk of developing CIP or CIM is about 30%
and the risk increases up to 50% in people with acute respira-
tory distress syndrome (Hermans 2008). The risk of developing
CIP or CIM is associated with a lengthy (more than one week)
stay in the intensive care unit (ICU), multi-organ failure (with
or without sepsis) and systemic inflammatory response syndrome(Bercker 2005; Hermans 2008). A systematic review estimated
the incidence of CIP and CIM at 46% (95% CI 43% to 49%)
among adults who had remained in the ICU for more than two
weeks, who were receiving mechanical ventilation and had sepsis
or multi-organ failure (Stevens 2007).
The short- and long-term impact of CIP and CIM are well de-
scribed (Hermans 2008; Herridge 2011; Ohtake 2012). The mus-
cle weakness associated with these conditions canprolong the need
for supported ventilation and delay weaning from a ventilator. In
turn, this can mean a longer stay in the ICU and in hospital, and
slower rehabilitation (Hermans 2008; Zanni 2010). Although full
recovery has been reported in approximately 50% of people with
CIM/CIP, improvement is related to the severity of the condition.People who are only mildly affected can recover within weeks, but
those with more severe weakness may take months to improve or,
in some cases, remain severely affected with partial or no recov-
ery (Hermans 2008). Clinical and neurophysiological signs may
remain for up to five years after discharge from hospital and may
lead to long-term paresis or paralysis (Herridge 2011).
Weakness due to CIP and CIM is a major cause of chronically im-
paired motor function that can affect activities of daily living and
quality of life. Physical rehabilitation of those affected is therefore
of great importance and interest.
Description of the interventionIn the last five years, research has suggested that physical reha-
bilitation may improve function or functional ability and may
prevent complications such as contractures in people with CIP
and CIM (Bemis-Dougherty 2012; Connolly 2012; Fan 2012;
Nordon-Craft 2012; Ohtake 2012). Physical rehabilitation inter-
ventions include physical and occupational therapy techniques,
such as stretching (e.g. ranging exercises), strength training and
3Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
6/25
mobility training (for example, training in dressing and transfers,
or to improve balance, sit-to-stand and walking) (Burtin 2009;
Fan 2012; Hanekom 2011; Herridge 2011; Nordon-Craft 2012).
There has, however, been no Cochrane review of the available lit-
erature on the efficacy and acceptability of physical rehabilitation
approaches to treat people who have developed CIP and CIM.
Why it is important to do this review
Advances in medical care, increased survival rates and better di-
agnosis of CIP and CIM, as well as the availability of more effec-
tive therapy, have highlighted the need for and potential value of
rehabilitation for people with critical illness. However, although
rehabilitation guidelines give recommendations, there is limited
evidence on which to base practice (Connolly 2012). People with
ICU-acquired weakness may be most likely to benefit from ongo-
ing rehabilitation (Connolly 2012). A recent special issue in the
journal Physical Therapy underlined the importance of the topic;
the authors concluded that physical rehabilitation approachesfor improving activities of daily living after CIP/CIM showed
some promising signs of effectiveness (Bemis-Dougherty 2012;
Nordon-Craft 2012), but there was a need for more evidence to
support evidence-based guidelines.
In addition to the question of whether physical rehabilitation in
general is beneficial, it is still unclear which specific rehabilitation
approaches are effective, and the most appropriate frequency and
intensity with which to apply them in practice (Connolly 2012).
There is currently no Cochrane systematic review in this area. We
therefore aim, inthis Cochrane review, to compile and assessall the
available literature about the effectiveness and safety of physical
rehabilitation in CIP and CIM, so as to provide comprehensive,
up-to-date evidence on which to base clinical practice.
O B J E C T I V E S
Our primary objective was to assess the effects of physical rehabil-
itation therapies and interventions for people with CIP and CIM
in improving activities of daily living such as walking, bathing,
dressing and eating. Secondary objectives were to assess effects on
muscle strength and quality of life, and to assess adverse effects of
physical rehabilitation.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered for inclusion randomised controlled trials (RCTs),
quasi-RCTs and randomised controlled cross-over trials. Quasi-
RCTs are trials in which the method used to allocate participants
to interventions is not truly random (for example, using date of
birth or hospital number, or alternation strategies).
Types of participants
We considered participants aged 18 and over in both inpatient
and outpatient settings, who have weakness and a confirmed or
probable diagnosis of CIP or CIM. We defined CIP and CIM as
stated above. We did not include studies where no such criteria
were explicitly fulfilled. We included studies with mixed popu-
lations of people with neurological conditions if we were able to
obtain the data for participants with weakness due to CIP or CIM.
Types of interventions
We considered for inclusion all trials of CIM and CIP that com-
pared any physical rehabilitation intervention, such as physiother-
apy or occupational therapy, or both, with any other interventions
that aimed to improve function and activities of daily living. Pos-
sible and typical interventions in this review might be cycling, sit-
to-stand training, walking and gait training, and neuromuscular
electrical stimulation to lower extremity muscle groups. There are
many varying interventions therefore we planned to describe the
individual interventions in more detail once they were identified.
We included all studies of inpatient and outpatient physical re-
habilitation in the acute and chronic phase that compared two or
more interventions; for example, neuromuscular electrical stimu-
lation versus usual therapy, or neuromuscular electrical stimula-
tion versus another active intervention (such as muscle strength
training, dressing exercises or gait training). The intervention and
control group must have received the same (usual) medication or
rehabilitation. We therefore allowed co-interventions as long as
they were the same for all randomised participants.
Types of outcome measures
The time frame for outcome measurement was immediately after
the intervention and at follow-up one year later.
Primary outcomes
Our primary outcome measure was activities of daily living (for
example, mobility, walking, transfers and self care), as measured
by validated outcome tools.
Measurement tools were the Functional Independence Measure
(FIM) (Dodds 1993), the Barthel Index (Mahoney 1965), and
other validated scales for the ICU such as the Functional Status
Score for ICU (FSS-ICU) (Zanni 2010), the Acute Care Index
4Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
7/25
of Function (ACIF) (Roach 1988), the Physical Function Out-
come Measure (PFIT) (Skinner 2009), or other validated mea-
sures. Measures of walking ability were gait speed in metres per
second and six-minute walking distance and other validated mea-
sures (Nordon-Craft 2012).
If studies used multiple scales to measure our primary outcome, we planned, in the absence of our preferred measures, to report all
scales and measures used.
Secondary outcomes
We reported the following secondary outcomes.
1. Muscle strength (as measured by, for example, the Medical
Research Council (MRC) Scale for Muscle Strength (Fan 2012)).
2. Quality of life measured by validated measures, such as the
Short Form-36 Health Survey (SF-36) (Skinner 2011), the
RAND-36 (Kaarlola 2006), or the Assessment of Quality of Life
(AQol) Utility Instrument (Denehy 2008).3. Frequency of adverse effects as a result of the intervention;
all serious adverse events defined as: life-threatening, requiring
prolonged hospitalisation or that are fatal; adverse events that
occur during the intervention or within 12 months of the
recruitment to the study.
We planned to report any information on costs in the ’Discussion’.
Search methods for identification of studies
Electronic searches
On 16 July 2014, we searched the Cochrane Neuromuscular Dis-
ease Group Specialized Register, the Cochrane Central Register of
Controlled Trials (CENTRAL 2014, Issue 6), MEDLINE (Jan-
uary 1966 to June 2014), EMBASE (January 1947 to June 2014),
CINAHL Plus (January 1937 to June 2014) and the Physio-
therapy Evidence Database (PEDro, http://www.pedro.org.au/).
The detailed search strategies are in the appendices: CENTRAL
( Appendix 1), MEDLINE ( Appendix 2), EMBASE ( Appendix 3),
CINAHL Plus ( Appendix 4) and Cochrane Neuromuscular Dis-
ease Group Specialized Register ( Appendix 5). There were no lan-
guage restrictions. The Cochrane Neuromuscular Disease Group
Trials Search Co-ordinator provided the search of the Specialized
Register; the review authors developed the other strategies.
We searched ClinicalTrials.gov (clinicaltrials.gov/) ( Appendix
6), the World Health Organization International Clinical Tri-
als Registry Platform (ICTRP) portal ( who.int/ictrp/en/) (
Appendix 7) and the European Union Clinical Trials Register (
clinicaltrialsregister.eu) for ongoing trials and further data about
included studies.
Searching other resources
We reviewed the bibliographies of any identified RCTs and con-
tacted the authors and known experts in the field to identify ad-
ditional published or unpublished data.
Data collection and analysis
Selection of studies
Two review authors (JM and MP) independently selected the eli-
gible trials based on the predefined selection criteria and resolved
disagreement through discussion with the other review authors. If
we needed further information, we contacted trial authors.
For additional methods described in the protocol (Mehrholz
2014a ), see Appendix 8.
R E S U L T S
Description of studies
Results of the search
The search strategy retrieved 3591 references to studies after dedu-
plication. The number of papers found by the search strategies in
the appendices were:
• MEDLINE - 96 papers;• EMBASE - seven papers;
• CINAHL Plus - 2666 papers;
• Cochrane Neuromuscular Disease Group Specialized
Register - 23 papers;
• CENTRAL - 808 papers.
The following databases are included in The Cochrane Library :• NHSEED (NHDS Economic Evaluation Database) - 22
papers;
• DARE (Database of Abstracts of Reviews of Effectiveness) -
15 papers;
• HTA (Health Technology Assessment Database) - one
paper.
Weexamined the titles and abstracts of these references, and sought
full-text copies of potentially relevant studies. We examined the
bibliographical references of these studies and so retrieved further
potential titles.
We identified a total of 3591 unique records through the searches.
After screening titles and abstracts, we excluded 3566 records and
obtained the full text of the remaining 25 articles. After further
5Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
http://www.pedro.org.au/http://clinicaltrials.gov/http://www.who.int/ictrp/en/http://www.clinicaltrialsregister.eu/http://www.clinicaltrialsregister.eu/http://www.who.int/ictrp/en/http://www.who.int/ictrp/en/http://www.who.int/ictrp/en/http://clinicaltrials.gov/http://www.pedro.org.au/http://www.pedro.org.au/http://www.pedro.org.au/
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
8/25
assessment, we determined that no studies met the review inclu-
sion criteria. There were no ongoing trials fulfilling our inclusion
criteria in ClinicalTrials.gov or ICTRP. The flow of references is
shown in Figure 1.
Figure 1. Study flow diagram.
6Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
9/25
Included studies
None of the retrieved studies met our inclusion criteria for this
review.
Excluded studies
The main reasons for exclusion were ’participants did not meet
our diagnostic criteria’ (22 studies) and ’not a RCT’ (two studies).
A full list of excluded studies is provided in the Characteristics of
excluded studies section.
Risk of bias in included studies
Not applicable.
Effects of interventions
No data were available for analysis.
D I S C U S S I O N
Summary of main results
We found no randomised controlled trials (RCTs) on the effects
of physical rehabilitation therapies for people with critical illness
myopathy (CIM) and polyneuropathy (CIP).
Overall completeness and applicability of evidence
The aim of our review was to identify RCTs but, using the de-
scribed methodology, our review team was unable to find any ev-
idence from RCTs for people with defined diagnoses of CIP and
CIM.
One could argue that in the absence of RCTs ’high quality’ non-
randomised trials should be mentioned from our search of liter-
ature. Although including non-randomised trials was beyond the
scope of this review, three review authors (JM, MP and SM) are
investigators in an ongoing cohort study (Mehrholz 2014b), and
we found a second example of exercise descriptions of physical re-
habilitation approaches for people with CIP/CIM (Berney 2012).
The authors of Berney 2012 described the safety and feasibility
of an exercise prescription. The investigators included a cohort of
74 people after five days following admission to the intensive care
unit (ICU) and applied a so called “protocolized” rehabilitation
and exercise training programme that commenced in the ICU and
continued on the acute care ward and for a further eight weeks
following hospital discharge as an outpatient programme (Berney
2012).
The investigators found that exercises (such as marching in place
and walking away from the bedside) that commence in the ICU
and continue through to an outpatient programme are safe and
feasible for survivors of critical illness. The authors used the Physi-
cal Function in ICU Test as a disability measure. However, the in-
clusion criteria were verybroad, because the investigators includedpeople admitted to the ICU for five or more days. Although many
of these people are at high risk of developing CIP/CIM, diagnos-
tic criteria for CIP/CIM were not clearly described. It is therefore
unclear how many people in this study developed a CIP/CIM ac-
cording to the diagnostic criteria described in our present review
(see Types of participants).
Mehrholz 2014b is a cohort study and still recruiting participants,
but includes people with ICU-acquired muscle weakness and a
properly definedand confirmed diagnosisof CIM/CIP. Theaim of
this study is to identify and to describe the amount and content of
physical rehabilitation exercises for people with CIP/CIM. Based
on an a priori sample size calculation, approximately 150 partici-
pants will be recruited from the ICU and followed up to one yearafter study onset. The investigators will describe the amount and
content of physical rehabilitation on a daily basis, using clinical
tests such as the Physical Function in ICU Test and the Func-
tional Status Score for the Intensive Care Unit scored as disability
measures and muscle strength and neuropsychological assessments
(Mehrholz 2014b). The investigators of this study use recovery of
walking function and mobility as primary outcomes (Mehrholz
2014b).
Both studies could therefore give valuable information about fu-
ture comparators in RCTs (see Implications for research).
Quality of the evidence
We found no RCT evidence.
Potential biases in the review process
We found no studies that met the pre-stated inclusion criteria.
The inclusion and exclusion process involved at least two review
authors and, where information was unclear, we contacted the
authors of studies for further clarification.
Agreements and disagreements with other studies or reviews
Other reviews have used broader definitions of CIM andCIP than
this review and they have included participants who are critically
ill or in a very early phase of ICU treatment, or they have de-
scribed interventions forthe prevention of CIM/CIP ( Adler 2012;
Doherty 2010; Kayambu 2013; Koo 2013).
For instance, a recent review about rehabilitation interventions
searched for studies including “adults post-ICU”, but the authors
did not use the definition of ICU-acquired or generalised weak-
ness and defined diagnoses of CIP and CIM (Mehlhorn 2014).
7Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
http://-/?-http://-/?-http://-/?-http://-/?-
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
10/25
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
11/25
R E F E R E N C E S
References to studies excluded from this review
Ali 2008 {published data only}∗ Ali NA, O’Brien JM Jr, Hoffmann SP, Phillips G, Garland
A, Finley JC, et al. Acquired weakness, handgrip strength,
and mortality in critically ill patients. American Journal of
Respiratory and Critical Care Medicine 2008;178(3):261–8.
Angelopoulos 2013 {published data only}∗ Angelopoulos E, Karatzanos E, Dimopoulos S, Mitsiou G,
Stefanou C, Patsaki I, et al. Acute microcirculatory effects
of medium frequency versus high frequency neuromuscular
electrical stimulation in critically ill patients - a pilot
study. Annals of Intensive Care 2013;3(1):39. [PUBMED:
24355422]
Berney 2003 {published data only}∗ Berney S, Denehy L. The effect of physiotherapy treatment
on oxygen consumption and haemodynamics in patients
who are critically ill. Australian Journal of Physiotherapy 2003;49(2):99–105.
Brummel 2014 {published data only}∗ Brummel NE, Girard TD, Ely EW, Pandharipande PP,
Morandi A, Hughes CG, et al. Feasibility and safety of early
combined cognitive and physical therapy for critically ill
medical and surgical patients: the Activity and Cognitive
Therapy in ICU (ACT-ICU) trial. Intensive Care Medicine
2014;40(3):370–9. [PUBMED: 24257969]
Burtin 2009 {published data only}∗ Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer
D, Troosters T, et al. Early exercise in critically ill patients
enhances short-term functional recovery. Critical Care
Medicine 2009;37(9):2499–505.
Caruso 2005 {published data only}∗ Caruso P, Denari SD, Ruiz SA, Bernal KG, Manfrin GM,
Friedrich C. Inspiratory muscle training is ineffective in
mechanically ventilated critically ill patients. Clinics (Sao
Paulo) 2005;60(6):479–84.
Delany 2003 {published data only}∗ Delaney CP, Zutshi M, Senagore AJ, Remzi FH, Hammel
J, Fazio VW. Prospective, randomized, controlled trial
between a pathway of controlled rehabilitation with early
ambulation and diet and traditional postoperative care after
laparotomy and intestinal resection. Diseases of the Colon
and Rectum 2003;46(7):851–9.
Denehy 2013 {published data only}∗ Denehy L, Skinner EH, Edbrooke L, Haines K, Warrillow S, Hawthorne G, et al. Exercise rehabilitation for patients
with critical illness: a randomized controlled trial with 12
months of follow-up. Critical Care 2013;17(4):R156.
Derde 2012 {published data only}∗ Derde S, Hermans G, Derese I, Güiza F, Hedström Y,
Wouters PJ. Muscle atrophy and preferential loss of myosin
in prolonged critically ill patients. Critical Care Medicine
2012;40(1):79–89.
Gerovasili 2009 {published data only}∗ Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E,
Politis P, Koroneos A, et al. Electrical muscle stimulation
preserves the muscle mass of critically ill patients: a
randomized study. Critical Care (London, England) 2009;13
(5):R161. [PUBMED: 19814793]
Karatzanos E, Gerovasili V, Zervakis D, Tripodaki E-
S, Apostolou K, Vasileiadis I, et al. Electrical muscle
stimulation: an effective form of exercise and early
mobilization to preserve muscle strength in critically ill
patients. Critical Care Research & Practice 2012; Vol.
2012:432752. [PUBMED: 22545212]
Gruther 2010 {published data only}∗ Gruther W, Kainberger F, Fialka-Moser V, Paternostro-
Sluga T, Quittan M, Spiss C, et al. Effects of neuromuscular
electrical stimulation on muscle layer thickness of knee
extensor muscles in intensive care unit patients: a pilot
study. Journal of Rehabilitation Medicine 2010;42(6):593–7.
[: 1650–1977]
Guerin 2004 {published data only}∗ Guerin C, Gaillard S, Lemasson S, Ayzac L, Girard R,
Beuret P, et al. Effects of systematic prone positioning
in hypoxemic acute respiratory failure: a randomized
controlled trial. JAMA 2004;292(19):2379–87.
Jackson 2012 {published data only}∗ Jackson J, Ely EW, Morey MC, Anderson VM, Denne
LB, Clune J, et al. Cognitive and physical rehabilitation
of ICU survivors: results of the RETURN randomized,
controlled pilot investigation. Critical Care Medicine 2012;
40(4):1088-97.
Kho 2012 {published data only}∗ Kho ME, Truong AD, Brower RG, Palmer JB, FanE, Needham DM. Neuromuscular electrical stimulation
for intensive care unit-acquired weakness: protocol and
methodological implications for a randomized, sham-
controlled, phase II trial. Physical Therapy 2012;92(12):
1564–79.
Meesen 2010 {published data only}∗ Meesen RL, Dendale P, Cuypers K, Berger J, Hermans
A, Thijs H, et al. Neuromuscular electrical stimulation
as a possible means to prevent muscle tissue wasting in
artificially ventilated and sedated patients in the intensive
care unit: A pilot study. Neuromodulation 2010;13(4):
315–20.
Muehling 2008 {published data only}∗ Muehling BM, Halter G, Lang G, Schelzig H, Steffen P,
Wagner F, et al. Prospective randomized controlled trial
to evaluate “fast-track” elective open infrarenal aneurysm
repair. Langenbecks Archiv fur Chirurgie 2008;393(3):
281–7. [1435–2451: (Electronic)]
Muehling 2009 {published data only}∗ Muehling B, Schelzig H, Steffen P, Meierhenrich R,
Sunder-Plassmann L, Orend KH. A prospective randomized
trial comparing traditional and fast-track patient care in
9Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
12/25
elective open infrarenal aneurysm repair. World Journal
of Surgery. 2009/01/13 2009; Vol. 33, issue 3:577–85.
[0364–2313: (Print)]
Nava 1998 {published data only}∗ Nava S. Rehabilitation of patients admitted to a
respiratory intensive care unit. Archives of Physical Medicine
Rehabilitation 1998;79(7):849–54.
Parry 2012 {published data only}∗ Parry SM, Berney S, Koopman R, Bryant A, El-Ansary
D, Denehy L. Early rehabilitation in critical care (eRiCC):
functional electrical stimulation with cycling protocol for a
randomised controlled trial. BMJ Open 2012;2(5):e001891.
Porta 2005 {published data only}∗ Porta R, Vitacca M, Gilè LS, Clini E, Bianchi L, Zanotti
E, et al. Supported arm training in patients recently weaned
from mechanical ventilation. Chest 2005;128(4):2511–20.
[: 0012–3692]
Poulsen 2011 {published data only}∗ Poulsen JB, Møller K, Jensen CV, Weisdorf S, Kehlet
H, Perner A. Effect of transcutaneous electrical musclestimulation on muscle volume in patients with septic shock.
Critical Care Medicine 2011;39(3):456–61.
Routsi 2010 {published data only}∗ Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E,
Pitsolis T, Nanas S. Electrical muscle stimulation prevents
critical illness polyneuromyopathy: a randomized parallel
intervention trial. Critical Care 2010;14(2):R74.
Schweickert 2009 {published data only}∗ Schweickert WD, Pohlman MC, Pohlman AS, Nigos
C, Pawlik AJ, Esbrook CL, et al. Early physical and
occupational therapy in mechanically ventilated, critically
ill patients: a randomised controlled trial. Lancet 2009;373
(9678):1874–82. [PUBMED: 19446324]
Troosters 2010 {published data only}∗ Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G,
Decramer M. Resistance training prevents deterioration in
quadriceps muscle function during acute exacerbations of
chronic obstructive pulmonary disease. American Journal
of Respiratory and Critical Care Medicine 2010;181(10):
1072–7.
Zanotti 2003 {published data only}∗ Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral
muscle strength training in bed-bound patients with
COPD receiving mechanical ventilation: effect of electrical
stimulation. Chest 2003;124(1):292–6.
Additional references
Adler 2012
Adler J, Malone D. Early mobilization in the intensive care
unit: a systematic review. Cardiopulmonary Physical Therapy
Journal 2012;23(1):5–13.
Bemis-Dougherty 2012
Bemis-Dougherty AR, Smith JM. What follows survival of
critical illness? Physical therapists’ management of patients
with post-intensive care syndrome. Physical Therapy 2013;
93(2):179–85.
Bercker 2005
Bercker S, Weber-Carstens S, Deja M, Grimm C, Kaisers
U. Critical illness polyneuropathy and myopathy in patients
with acute respiratory distress syndrome. Critical Care
Medicine 2005;33(4):711–5.
Berney 2012
Berney S, Haines K, Skinner EH, Denehy L. Safety
and feasibility of an exercise prescription approach to
rehabilitation across the continuum of care for survivors of
critical illness. Physical Therapy 2012;92(12):1524–35.
Bolton 2005
Bolton CF. Neuromuscular manifestations of critical illness.
Muscle & Nerve 2005;32(2):140–63.
Connolly 2012
Connolly B, Denehy L, Brett S, Elliott D, Hart N. Exercise
rehabilitation following hospital discharge in survivors of
critical illness: an integrative review. Critical Care 2012;16
(3):226.
Denehy 2008
Denehy L, Berney S, Skinner E, Edbrooke L, Warrillow S,
Hawthorne G, et al. Evaluation of exercise rehabilitation
for survivors of intensive care: protocol for single blind
randomised controlled trial. Open Critical Care Medicine
Journal 2008;1:39–47.
Dodds 1993
Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation
of the functional independence measurement and its
performance among rehabilitation inpatients. Archives of
Physical Medicine and Rehabilitation 1993;74(5):531–6.
Doherty 2010
Doherty N, Steen CD. Critical illness polyneuromyopathy
(CIPNM); rehabilitation during critical illness. Therapeutic
options in nursing to promote recovery: a review of theliterature. Intensive and Critical Care Nursing 2010;26(6):
353–62.
Fan 2012
Fan E. Critical illness neuromyopathy and the role of
physical therapy and rehabilitation in critically ill patients.
Respiratory Care 2012;57(6):933-44; discussion 944-6.
GRADEpro 2014
Jan Brozek, Andrew Oxman, Holger Schünemann.
GRADEpro. 3.2 for Windows. Jan Brozek, Andrew
Oxman, Holger Schünemann, 2008.
Hanekom 2011
Hanekom S, Gosselink R, Dean E, van Aswegen H, Roos
R, Ambrosino N, et al. The development of a clinicalmanagement algorithm for early physical activity and
mobilization of critically ill patients: synthesis of evidence
and expert opinion and its translation into practice. Clinical
Rehabilitation 2011;25(9):771–87.
Hermans 2008
Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe
G. Clinical review: critical illness polyneuropathy and
myopathy. Critical Care 2008;12(6):238.
10Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
13/25
Hermans 2014
Hermans G, De Jonghe B, Bruyninckx F, Van den
Berghe G. Interventions for preventing critical illness
polyneuropathy and critical illness myopathy. Cochrane
Database of Systematic Reviews 2014, Issue 1. [DOI:
10.1002/14651858.CD006832.pub3]
Herridge 2011
Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-
Granados N, Cooper A, et al. Functional disability 5 years
after acute respiratory distress syndrome. New England
Journal of Medicine 2011;364(14):1293–304.
Higgins 2002
Higgins JP, Thompson SG. Quantifying heterogeneity in a
meta-analysis. Statistics in Medicine 2002;21(11):1539–58.
Higgins 2011
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0
[updated March 2011]. The Cochrane Collaboration,
2011. Available from www.cochrane-handbook.org.
Higgins 2011a
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter
8: Assessing risk of bias in included studies. In: Higgins
JPT, Green S (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March
2011]. The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.
Higgins 2011b
Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9:
Analysing data and undertaking meta-analyses. In: Higgins
JPT, Green S (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March
2011]. The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.
Higgins 2011c
Deeks JJ, Higgins JPT, Altman DG (editors). Chapter
16: Special topics in statistics. In: Higgins JPT, Green S
(editors). Cochrane Handbook for Systematic Reviews
of Interventions Version 5.1.0 [updated March 2011].
The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.
Kaarlola 2006
Kaarlola A, Tallgren M, Pettilä V. Long-term survival,
quality of life, and quality-adjusted life-years among
critically ill elderly patients. Critical Care Medicine 2006;34
(8):2120–6.
Kayambu 2013
Kayambu G, Boots R, Paratz J. Physical therapy for the
critically ill in the ICU: a systematic review and meta-
analysis. Critical Care Medicine 2013;41(6):1543–54.
Koo 2013
Koo KKY, Fan E. ICU-acquired weakness and early
rehabilitation in the critically ill. Journal of Clinical
Outcomes Management 2013;20(5):223–31.
Lacomis 2000
Lacomis D, Zochodne DW, Bird SJ. Critical illness
myopathy. Muscle & Nerve 2000;23(12):1785–8.
Latronico 2011
Latronico N, Bolton CF. Critical illness polyneuropathy and
myopathy: a major cause of muscle weakness and paralysis.
Lancet Neurology 2011;10(10):931–41.
Mahoney 1965
Mahoney FI, Barthel DW. Functional evaluation: the
Barthel Index. Maryland State Medical Journal 1965;14:
61–5.
Mehlhorn 2014
Mehlhorn J, Freytag A, Schmidt K, Brunkhorst FM, Graf
J, Troitzsch U, et al. Rehabilitation interventions for
postintensive care syndrome: a systematic review. Critical
Care Medicine 2014;42(5):1263–71.
Mehrholz 2014b
Mehrholz J, Mückel S, Oehmichen F, Pohl M. The General
Weakness Syndrome Therapy (GymNAST) study: protocol
for a cohort study on recovery on walking function. BMJ Open 2014;4(10):e006168.
Nordon-Craft 2012
Nordon-Craft A, Moss M, Quan D, Schenkman M.
Intensive care unit-acquired weakness: implications for
physical therapist management. Physical Therapy 2012;92
(12):1494–506.
Ohtake 2012
Ohtake PJ, Strasser DC, Needham DM. Rehabilitation for
people with critical illness: taking the next steps. Physical
Therapy 2012;92(12):1484-8. Erratum in Physical Therapy
2013;93(2):282.
RevMan 2014
The Nordic Cochrane Centre, The Cochrane Collaboration.Review Manager (RevMan). 5.3. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014.
Roach 1988
Roach KE, Van Dillen LR. Development of an acute care
index of functional status for patients with neurologic
impairment. Physical Therapy 1988;68(7):1102–8.
Skinner 2009
Skinner EH, Berney S, Warrillow S, Denehy L.
Development of a physical function outcome measure
(PFIT) and a pilot exercise training protocol for use in
intensive care. Critical Care and Resuscitation 2009;11(2):
110–5.
Skinner 2011Skinner EH, Warrillow S, Denehy L. Health-related quality
of life in Australian survivors of critical illness. Critical Care
Medicine 2011;39(8):1896–905.
Stevens 2007
Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA,
Pronovost PJ, Needham DM. Neuromuscular dysfunction
acquired in critical illness: a systematic review. Intensive
Care Medicine 2007;33(11):1876–91.
11Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
14/25
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
15/25
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ali 2008 Cohort study. Not a RCT
Angelopoulos 2013 Included a mix of participants with and without ICU-acquired weakness; no clear description or confirmed or
probable diagnosis of CIP or CIM
Berney 2003 No description of participants with generalised weakness and a confirmed or probable diagnosis of CIP or
CIM
Brummel 2014 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Burtin 2009 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Caruso 2005 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Delany 2003 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Denehy 2013 Included critically ill participants but did not include people with a confirmed or probable diagnosis of CIP
or CIM
Derde 2012 Not a RCT
Gerovasili 2009 Included critically ill participants but did not include people with generalised weakness and a confirmed or
probable diagnosis of CIP or CIM
Gruther 2010 People with myopathy or neuromuscular disorders were excluded; did not include people with generalised
weakness and a confirmed or probable diagnosis of CIP or CIM
Guerin 2004 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Jackson 2012 Did not include people with weakness and a confirmed or probable diagnosis of CIP or CIM
Kho 2012 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Meesen 2010 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Muehling 2008 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Muehling 2009 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Nava 1998 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Parry 2012 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
13Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
16/25
(Continued)
Porta 2005 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Poulsen 2011 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Routsi 2010 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Schweickert 2009 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Troosters 2010 Did not include people with generalised weakness and a confirmed or probable diagnosis of CIP or CIM
Zanotti 2003 People with myopathy orneurologic conditions were excluded;did notincludepeople with generalisedweakness
and a confirmed or probable diagnosis of CIP or CIM
CIM: critical illness myopathy; CIP: critical illness polyneuropathy; ICU: intensive care unit; RCT: randomised controlled trial
14Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
17/25
D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1“randomised controlled trial”:pt (Word variations have been searched)
#2“controlled clinical trial”:pt (Word variations have been searched)
#3randomized:ti,ab,kw (Word variations have been searched)
#4placebo:ti,ab,kw (Word variations have been searched)
#5drug therapy:ti,ab,kw (Word variations have been searched)
#6randomly:ti,ab,kw (Word variations have been searched)
#7trial:ti,ab,kw (Word variations have been searched)
#8groups:ti,ab,kw (Word variations have been searched)#9#1 or #2 or #3 or #4 or #5 or #6 or #6 or #7 or #8
#10MeSH descriptor: [Animals] explode all trees
#11#9 not #10
#12MeSH descriptor: [Polyneuropathies] this term only
#13MeSH descriptor: [Muscle Weakness] this term only
#14MeSH descriptor: [Rhabdomyolysis] this term only
#15MeSH descriptor: [Quadriplegia] this term only
#16MeSH descriptor: [Paresis] this term only
#17neuromuscular manifestation? (Word variations have been searched)
#18(polyneuropath* or myopath*) (Word variations have been searched)
#19polyneuromyopath* (Word variations have been searched)
#20neuromuscular disorder? (Word variations have been searched)
#21neuromuscular disease? (Word variations have been searched)#22paresis (Word variations have been searched)
#23quadriplegia (Word variations have been searched)
#24weakness (Word variations have been searched)
#25neuromyopath* (Word variations have been searched)
#26motor syndrome (Word variations have been searched)
#27muscle function (Word variations have been searched)
#28MeSH descriptor: [Muscle Strength] this term only
#29(muscle strength or respiratory failure) (Word variations have been searched)
#30#12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28
#31MeSH descriptor: [Intensive Care] this term only
#32MeSH descriptor: [Critical Illness] this term only
#33intensive care (Word variations have been searched)
#34critical* ill* (Word variations have been searched)#35MeSH descriptor: [Ventilator Weaning] this term only
#36MeSH descriptor: [Respiration, Artificial] this term only
#37#31 or #32 or #33 or #34 or #35 or #36
#38MeSH descriptor: [Electric Stimulation Therapy] this term only
#39electrostimulation (Word variations have been searched)
#40(electric* next/2 stimulation) (Word variations have been searched)
#41((leg or lower) next/2 (limb* or extremit*)) (Word variations have been searched)
#42(#38 or #39 or #40) and #41
15Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
18/25
#43MeSH descriptor: [Exercise] explode all trees
#44MeSH descriptor: [Physical Therapy Modalities] this term only
#45physiotherap* or (physical therap*) (Word variations have been searched)
#46MeSH descriptor: [Exercise Therapy] explode all trees
#47MeSH descriptor: [Musculoskeletal Manipulations] this term only
#48MeSH descriptor: [Occupational Therapy] this term only #49MeSH descriptor: [Recovery of Function] this term only
#50MeSH descriptor: [Activities of Daily Living] this term only
#51strength training (Word variations have been searched)
#52muscle training (Word variations have been searched)
#53(physical next/5 rehabilitation)
#54#42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53
#55#11 and #30 and #37 and #54
Date of search: 23 June 2014
Number of records retrieved: 808
Appendix 2. MEDLINE (OvidSP) search strategy
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
12. Polyneuropathies/
13. Muscle Weakness/
14. Rhabdomyolysis/15. Quadriplegia/
16. Paresis/
17. neuromuscular manifestation$1.tw.
18. (polyneuropath$ or myopath$).tw.
19. polyneuromyopath$.tw.
20. neuromuscular disorder$.tw.
21. neuromuscular disease$.tw.
22. paresis.tw.
23. quadriplegia.tw.
24. weakness.tw.
25. neuromyopath$.tw.
26. motor syndrome.tw.
27. muscle function.tw.28. muscle strength/
29. (muscle strength or respiratory failure).tw.
30. or/12-29
31. Intensive Care/
32. Critical Illness/
33. intensive care.tw.
34. critical$ ill$.tw.
35. ventilator weaning/
16Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
19/25
36. respiration, artificial/
37. or/31-36
38. electric stimulation therapy/ or electrostimulation.mp. or (electric$ adj2 stimulation).tw.
39. ((leg or lower) adj2 (limb$ or extremit$)).tw.
40. 38 and 39
41. exp Exercise/42. physical therapy modalities/ or physiotherap$.tw. or physical therap$.tw.
43. exp Exercise Therapy/
44. Musculoskeletal Manipulations/
45. Occupational Therapy/
46. recovery of function/
47. “Activities of Daily Living”/
48. strength training.mp.
49. muscle training.mp.
50. (physical adj5 rehabilitation).tw.
51. or/40-50
52. 11 and 30 and 37 and 51
Date of search: 23 June 2014
Number of records retrieved: 96
Appendix 3. EMBASE (OvidSP) search strategy
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
12. Polyneuropathies/
13. Muscle Weakness/
14. Rhabdomyolysis/
15. Quadriplegia/
16. Paresis/
17. neuromuscular manifestation$1.tw.
18. (polyneuropath$ or myopath$).tw.
19. polyneuromyopath$.tw.
20. neuromuscular disorder$.tw.
21. neuromuscular disease$.tw.
22. paresis.tw.
23. quadriplegia.tw.24. weakness.tw.
25. neuromyopath$.tw.
26. motor syndrome.tw.
27. muscle function.tw.
28. muscle strength/
29. (muscle strength or respiratory failure).tw.
30. or/12-29
31. Intensive Care/
17Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
20/25
32. Critical Illness/
33. intensive care.tw.
34. critical$ ill$.tw.
35. ventilator weaning/
36. respiration, artificial/
37. or/31-3638. electric stimulation therapy/ or electrostimulation.mp. or (electric$ adj2 stimulation).tw.
39. ((leg or lower) adj2 (limb$ or extremit$)).tw.
40. 38 and 39
41. exp Exercise/
42. physical therapy modalities/ or physiotherap$.tw. or physical therap$.tw.
43. exp Exercise Therapy/
44. Musculoskeletal Manipulations/
45. Occupational Therapy/
46. recovery of function/
47. “Activities of Daily Living”/
48. strength training.mp.
49. muscle training.mp.
50. (physical adj5 rehabilitation).tw.51. or/40-50
52. 11 and 30 and 37 and 51
Date of search: 23 June 2014
Number of records retrieved: 7
Appendix 4. CINAHL (EBSCOhost) search strategy
S56 S11 AND S30 AND S37 AND S55
S55 S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54
S54 TX (physical n5 rehabilitation)
S53 MH muscle training
S52 MH strength training
S51 MH activities of daily living
S50 MH recovery of function
S49 MH occupational therapy
S48 MH Musculoskeletal Manipulations
S47 MW exercise therapy
S46 TX physiotherap* or (physical therap*)
S45 MW physical therapy modalities
S44 MH exercise
S43 S41 AND S42
S42 S38 OR S39 OR S40
S41 TX ((leg or lower) n2 (limb# or extremit*))
S40 TX (electric* N2 stimulation)
S39 TX electrostimulation
S38 MH electric stimulation therapy S37 S31 OR S32 OR S33 OR S34 OR S35 OR S36
S36 MH respiration, artificial
S35 MH ventilator weaning
S34 TX critical* ill*
S33 TX intensive care
S32 MH Critical Illness
S31 MH Intensive Care
18Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
21/25
S30 S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26
OR S27 OR S28 OR S29
S29 TX (muscle strength or respiratory failure)
S28 MH muscle strength
S27 TX muscle function
S26 TX motor syndromeS25 TX neuromyopath*
S24 TX weakness
S23 TX quadriplegia
S22 TX paresis
S21 TX neuromuscular disease#
S20 TX neuromuscular disorder#
S19 TX polyneuromyopath*
S18 TX (polyneuropath* or myopath*)
S17 TX neuromuscular manifestation#
S16 MW Paresis
S15 MH Quadriplegia
S14 MH Rhabdomyolysis
S13 MH muscle weaknessS12 MH polyneuropathies
S11 s9 not s10
S10 MW animals
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S8 AB groups
S7 AB trial
S6 AB randomly
S5 TX drug therapy
S4 AB placebo
S3 AB randomized
S2 MH controlled clinical trial
S1 MH randomized controlled trials
Date of search: 23 June 2014Number of records retrieved: 2666
Appendix 5. NMD Specialized Register (CRS) search strategy
#1 Rhabdomyolysis or Quadriplegia or Paresis or polyneuropath* or myopath* or polyneuromyopath* or weakness or neuromyopath*
[REFERENCE] [STANDARD]
#2 “neuromuscular disorder*” or “neuromuscular disease*” [REFERENCE] [STANDARD]
#3 neuromuscular NEXT manifestation* [REFERENCE] [STANDARD]
#4 “ motor syndrome” or “muscle function” or “muscle strength” [REFERENCE] [STANDARD]
#5 “muscle strength” or “respiratory failure” [REFERENCE] [STANDARD]
#6 “muscular atrophy” or “muscle wasting” [REFERENCE] [STANDARD]
#7 #1 or #2 or #3 or #4 or #5 or #6 [REFERENCE] [STANDARD]
#8 “Intensive Care” [REFERENCE] [STANDARD]#9 “Critical Illness” or “critically ill”or “intensive care” or “ventilator weaning”or “artificial respiration” [REFERENCE] [STANDARD]
#10 MeSH DESCRIPTOR Respiration, Artificial [REFERENCE] [STANDARD]
#11 #8 or #9 or #10 [REFERENCE] [STANDARD]
#12 electrostimulation or electric* NEAR2 stimulation [REFERENCE] [STANDARD]
#13 rehabilitation or “breathing exercise” or “breathing exercises” [REFERENCE] [STANDARD]
#14 MeSH DESCRIPTOR Physical Therapy Modalities Explode All [REFERENCE] [STANDARD]
#15 “recovery of function” or convalescence [REFERENCE] [STANDARD]
#16 MeSH DESCRIPTOR Physical Stimulation Explode All [REFERENCE] [STANDARD]
19Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
22/25
#17 “resistance training” or “exercise therapy” or “physical therapy” or physiotherapy [REFERENCE] [STANDARD]
#18 “occupational therapy” or training or “muscle stimulation” [REFERENCE] [STANDARD]
#19 #12 or #13 or #14 or #15 or #16 or #17 or #18 [REFERENCE] [STANDARD]
#20 #7 and #11 and #19 [REFERENCE] [STANDARD]
#21 (#7 and #11 and #19) AND (INREGISTER) [REFERENCE] [STANDARD]
#22 #11 and #19 [REFERENCE] [STANDARD]
Appendix 6. ClinicalTrials.gov search strategy
#1 critic* ill*
#2 critical illness myopathy
#3 critical illness neuropathy
#4 critical illness neuromyopathy
#5 #1 OR #2 OR #3 OR #4
Date of search: 8 July 2014
Number of records retrieved: 24
Appendix 7. ICTRP search strategy
Advanced search:critic* AND ill* in the title;
myo* OR neuro* OR neuromyo* in the condition
Date of search: 08 July 2014
Number of records retrieved: 3
Appendix 8. Additional methods
We described the following methods in the protocol for this review (Mehrholz 2014a ).
Data collection and analysis
Data extraction and management
We proposed that two authors (MP and JM) would extract outcome data from the selected trials independently using a data collection
form. If one of the review authors was involved in an included trial, another review author would extract data from this trial.
The review authors proposed to extract the following data (according to the Cochrane Handbook for Systematic Reviews of Interventions Table 7.3.a):
1. source;
2. eligibility;
3. participants (important imbalances in prognostic factors at baseline, country, number of participants, age, gender, inclusion and
exclusion criteria, educational background, socioeconomic status, cognition, pre-existing neurological impairment(s), neurological
history);
4. interventions;
5. outcomes and measurement time point;
6. comparison (details of interventions in treatment and control groups, duration of treatment, details of co-intervention in thegroups;
7. results;
8. funding source and conflicts of interest among investigators; and
9. miscellaneous.
Two review authors (MP and JM) would have checked the extracted data for agreement. If they had not been able to reach a consensus,
a third review author would have arbitrated.
If necessary, the review authors would have contacted trial authors for more information. We planned to report the outcome of efforts
to source missing data in the review.
20Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
23/25
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
24/25
Data synthesis
We proposed using a random-effects model, regardless of the level of heterogeneity found with the I2 statistic. Thus, in cases of
heterogeneity, we would not have violated the preconditions of a fixed-effect model approach.
If the review had included more than one comparison, which could not be included in the same analysis, we would have reported the
results for each comparison separately.
’Summary of findings’ table
We planned to use GRADEpro software to create a ’Summary of findings’ table with the following outcomes: activities, muscle strength,
quality of life and adverse effects (GRADEpro 2014). The planned time points for all outcomes in the ’Summary of findings’ table
were immediately after the intervention and at follow-up one year later. We planned to use the five GRADE considerations (study
limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of a body of evidence (studies that
contributed data for the prespecified outcomes). We would have used the methods and recommendations described in Chapter 12 of
the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We would have justified all decisions to down- or up-grade the quality of evidence using footnotes.
Subgroup analysis and investigation of heterogeneity
We proposed three subgroup analyses as follows:1. Duration of illness or critical condition: acute/subacute phase (first six months of initiated intervention) versus chronic phase
(illness of more than six months’ duration and interventions initiated accordingly).
2. Use of definitions of CIP and CIM: use of definitive definition of CIP and CIM in studies versus use of probable definition.
3. Imbalance of prognostic factors at baseline (such as age, duration of illness and duration of ventilation).
We would have considered meta-regression as an extension to subgroup analyses when there were more than 10 studies in a meta-
analysis.
Sensitivity analysis
If a sufficient number of studies had been identified we planned to test the robustness of results by conducting a sensitivity analysis,
removing studies at high or unclear risk of bias (for example, high or unclear versus low risk of bias from method of randomisation).
C O N T R I B U T I O N S O F A U T H O R S
All authors contributed to the conception and design of the protocol and approved the final text. All authors were involved in all stages
of the review. JM screened titles and abstracts of publications identified by the searches. MP and JM would have extracted trial and
outcome data from the selected trials and analysed outcome data. JK and MP would have assessed the risk of bias in included studies.
D E C L A R A T I O N S O F I N T E R E S T
Jan Mehrholz: none known.
Marcus Pohl: none known.
Joachim Kugler: none known.
Jane Burridge: none known.
Simone Mückel: none known.
Bernhard Elsner: none known.
22Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
-
8/9/2019 Polineuropatía Paciente Critico Cochrane 2015
25/25
S O U R C E S O F S U P P O R T
Internal sources
• Wissenschaftliches Institut, Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH, An
derWolfsschlucht 1-2, 01731 Kreischa, Germany.• Lehrstuhl Therapiewissenschaften, SRH Fachhochschule für Gesundheit Gera gGmbH, Hermann-Drechsler-Str. 2, 07548
Gera, Germany.
• Gesundheitswissenschaften/Public Health, Medizinische Fakultät Carl Gustav Carus der TU Dresden, Fetscherstr. 74, 01307
Dresden, Germany.
• University of Southampton, UK.
External sources
• No sources of support supplied
D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E WDue to the lack of included studies, we were unable to implement many of our proposed methods.
23Physical rehabilitation for critical illness myopathy and neuropathy (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.